Partner at DLA Piper (New York, NY)
MICHAEL DOUGHERTY‚ Special Counsel Litigation Intellectual Property at Cadwalader‚ Wickersham & Taft LLP‚ has 25 years of experience litigating patent cases in a wide variety of technologies in the U.S. District Courts‚ the U.S. Court of Appeals for the Federal Circuit‚ and the U.S. International Trade Commission. He has particular expertise in the fields of pharmaceutical products and biotechnology. Recent highlights include successfully representing Roche Palo Alto LLC in a HatchWaxman suit against Ranbaxy‚ which ultimately resulted in Ranbaxy stipulating to the validity‚ enforceability‚ and infringement of Roche's patent. Roche Palo Alto LLC v. Ranbaxy Labs. Ltd. and Ranbaxy‚ Inc.‚ Civil Action No. 062003 (FLW) (D.N.J. Order‚ Aug. 26‚ 2010). He argued in the U.S. Court of Appeals for the Federal Circuit on behalf of HoffmannLa Roche Inc. in support of the International Trade Commission's dismissal of a complaint brought against Roche by Amgen‚ Inc. Amgen v. ITC‚ 565 F.3d 846 (Fed. Cir. 2009). Earlier‚ he was part of the team that successfully represented Roche in the underlying ITC investigation‚ In the Matter of Certain Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoietin‚ Inv. No. 337TA568. Mr. Dougherty earned his J.D. from the MarshallWythe School of Law‚ College of William & Mary‚ where he was Executive Editor of the William & Mary Law Review‚ and his B.A.‚ with honors‚ from Case Western Reserve University.